ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

ClinicalTrials.gov ID: NCT02985684

Public ClinicalTrials.gov record NCT02985684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

GORE® CARDIOFORM ASD Occluder Clinical Study: A Study to Evaluate Safety and Efficacy in the Treatment of Transcatheter Closure of Ostium Secundum Atrial Septal Defects (ASDs) - The Gore ASSURED Clinical Study

Study identification

NCT ID
NCT02985684
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
W.L.Gore & Associates
Industry
Enrollment
125 participants

Conditions and interventions

Interventions

  • GORE® CARDIOFORM ASD Occluder Device

Device

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 9, 2017
Primary completion
Jul 29, 2018
Completion
Sep 28, 2022
Last update posted
Mar 16, 2026

2017 – 2022

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
20
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
University of California-Los Angeles Los Angeles California 90095
The Children's Hospital of Colorado Aurora Colorado 80218
Yale University School of Medicine New Haven Connecticut 06520
Nicklaus Children's Hospital Miami Florida 33155
Children's Healthcare at Egleston Atlanta Georgia 30322
Riley Hospital for Children Indianapolis Indiana 46202
Massachusetts General Hospital Boston Massachusetts 02114
Children's Hospital Boston Boston Massachusetts 02115
University of Michigan Ann Arbor Michigan 48109
Children's Hospital of Michigan Detroit Michigan 48201
Mayo Clinic - Rochester Rochester Minnesota 55905
Mount Sinai Medical Center New York New York 10029
Columbia University Medical Center/New York Presbyterian Hospital New York New York 10032
Atrium Health Charlotte North Carolina 28203
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Cleveland Clinic Foundation Cleveland Ohio 44195
Nationwide Children's Hospital Columbus Ohio 43205
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19014
Texas Children's Hospital Houston Texas 77030
University of Utah Salt Lake City Utah 84113
Children's Hospital & Regional Medical Center Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02985684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 16, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02985684 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →